Download | < Back |
13 Aug 2024 | |
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2025, as amended, we wish to inform that CRISIL Ratings Limited ("CRISIL") has upgraded its ratings on the Bank Loan Facilities of Emcure Pharmaceuticals Limited. | |
View all announcements for Emcure Pharmaceuticals Ltd | Source: BSE India |